These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26370368)

  • 1. Effects of Cardiac Resynchronization Therapy on Ventricular Electrical Remodeling in Patients With Heart Failure.
    Zhang J; Xing Q; Zhou X; Zhang Y; Li Y; Li J; Tang B
    Int Heart J; 2015; 56(5):495-9. PubMed ID: 26370368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time Course of Electrical Remodeling of Native Conduction After Cardiac Resynchronization Therapy and Its Impact on Clinical Outcome.
    Cvijić M; Žižek D; Antolič B; Zupan I
    J Card Fail; 2017 Mar; 23(3):257-261. PubMed ID: 27989870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrical remodelling in cardiac resynchronization therapy: decrease in intrinsic QRS duration.
    Mischke K; Knackstedt C; Fache K; Reith S; Rana O; Saygili E; Gemein C; Becker M; Marx N; Schauerte P
    Acta Cardiol; 2011 Apr; 66(2):175-80. PubMed ID: 21591575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin is associated with reverse remodeling after cardiac resynchronization therapy in patients with heart failure and ventricular dyssynchrony.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Piccolo R; Galasso G; Reiter RJ
    Int J Cardiol; 2016 Oct; 221():359-63. PubMed ID: 27404706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of Left Ventricular Size and Sex on Outcome of Cardiac Resynchronization Therapy Among Patients With a Narrow QRS Duration in the EchoCRT Trial.
    Varma N; Sogaard P; Bax JJ; Abraham WT; Borer JS; Dickstein K; Singh JP; Gras D; Holzmeister J; Brugada J; Ruschitzka F
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29807890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure.
    De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A
    Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The QRS narrowing index predicts reverse left ventricular remodeling following cardiac resynchronization therapy.
    Rickard J; Popovic Z; Verhaert D; Sraow D; Baranowski B; Martin DO; Lindsay BD; Varma N; Tchou P; Grimm RA; Wilkoff BL; Chung MK
    Pacing Clin Electrophysiol; 2011 May; 34(5):604-11. PubMed ID: 21276023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incremental value of larger interventricular conduction time in improving cardiac resynchronization therapy outcome in patients with different QRS duration.
    D'Onofrio A; Botto G; Mantica M; LA Rosa C; Occhetta E; Verlato R; Molon G; Ammendola E; Villani GQ; Bongiorni MG; Bianchi V; Gelmini GP; Valsecchi S; Ciardiello C
    J Cardiovasc Electrophysiol; 2014 May; 25(5):500-506. PubMed ID: 24494797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic importance of postoperative QRS widening in patients with heart failure receiving cardiac resynchronization therapy.
    Menet A; Bardet-Bouchery H; Guyomar Y; Graux P; Delelis F; Castel AL; Heuls S; Cuvelier E; Gevaert C; Ennezat PV; Tribouilloy C; Maréchaux S
    Heart Rhythm; 2016 Aug; 13(8):1636-43. PubMed ID: 27236025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E/A ratio before cardiac resynchronization therapy predicts left ventricle reverse remodeling.
    Iori M; Bottoni N; Quartieri F; Manari A
    Minerva Cardioangiol; 2014 Aug; 62(4):305-9. PubMed ID: 25012099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.
    Brenyo A; Rao M; Barsheshet A; Cannom D; Quesada A; McNitt S; Huang DT; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):442-8. PubMed ID: 23252875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of coronary flow reserve for left ventricular functional improvement after cardiac resynchronization therapy in patients with dilated cardiomyopathy.
    Djordjevic Dikic A; Nikcevic G; Raspopovic S; Jovanovic V; Tesic M; Beleslin B; Stepanovic J; Giga V; Milasinovic G
    Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1344-9. PubMed ID: 25053732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful reduction of intraventricular asynchrony is associated with superior response to cardiac resynchronization therapy.
    Dreger H; Borges AC; Baumann G; Melzer C
    Cardiovasc Ultrasound; 2010 Sep; 8():35. PubMed ID: 20809960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of QRS duration to response to cardiac resynchronization therapy.
    Sassone B; Gambetti S; Bertini M; Beltrami M; Mascioli G; Bressan S; Fucà G; Pacchioni F; Pedaci M; Michelotti F; Bacchi Reggiani ML; Padeletti L
    Am J Cardiol; 2015 Jan; 115(2):214-9. PubMed ID: 25465934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.
    Gold MR; Thébault C; Linde C; Abraham WT; Gerritse B; Ghio S; St John Sutton M; Daubert JC
    Circulation; 2012 Aug; 126(7):822-9. PubMed ID: 22781424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of notched duration to predict response to cardiac resynchronization therapy.
    Balci MM; Balci KG; Sen F; Maden O; Unal S; Selcuk MT; Selcuk H
    Scand Cardiovasc J; 2015 Aug; 49(4):200-6. PubMed ID: 25920477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined score using clinical, electrocardiographic, and echocardiographic parameters to predict left ventricular remodeling in patients having had cardiac resynchronization therapy six months earlier.
    Brunet-Bernard A; Maréchaux S; Fauchier L; Guiot A; Fournet M; Reynaud A; Schnell F; Leclercq C; Mabo P; Donal E
    Am J Cardiol; 2014 Jun; 113(12):2045-51. PubMed ID: 24793667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.